Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,390.00    -65.00 (-1.19%)
Bid:
5,410.00
Ask:
5,420.00
Spread: 10.00 (0.185%)
Market Cap: £3.92b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Interim Management Statement

15 Oct 2009 11:06

RNS Number : 8319A
Renishaw PLC
15 October 2009
 



Renishaw plc

Interim Management Statement

This statement has been prepared for the Group and relates to the three months ended 30th September 2009. It contains unaudited information that covers the first quarter and the period since the quarter end to the date of this interim management statement.

Trading activity

The recent improvements in order intake and revenue reported on 29th September 2009 have continued, but are still substantially below that of twelve months ago. In the first quarter, good growth has been experienced in the Far East, compared with the last two quarters of the previous year. In product terms, the strongest increase in demand has been for our Encoder products and there has been an encouraging recovery for most other product lines, with order intake still running ahead of sales. Spectroscopy has seen an increase in sales compared with the same quarter last year.

In the three-month period, the operating profit amounted to £1.3m and the profit before tax amounted to £2.0m compared to £9.8m last year on revenue of £32.5m, down from £53.0m last year. Revenue at previous year exchange rates would have been lower by £2.3m and the profit before tax lower by £1.2m.

The Board has restored half the voluntary 20% reduction in salaries from 1st October 2009 to 31st December 2009 at which time salaries will be fully restored. Provision will be made for further payment, which may take employees back up to full salary for part of the period, depending upon group performance up to 31st December 2009 and, if appropriate, will be paid within the December 2009 payroll. 

The Group continues to invest strongly in research and development programmes in both the Metrology and Healthcare sectors and a number of new products are being introduced in this financial year, some of which were exhibited at the EMO exhibition held last week in MilanItaly.

Current indications are that there will be an improvement in Group profits for the year, although the overall outcome is expected to be well below the level of two years ago. 

Financial position, significant events and transactions

The Group has a strong balance sheet and there is a continuing focus on working capital management. At 30th September 2009, net cash balances amounted to £21.9m.

There have been no other significant events or transactions that could have had a material impact on the financial position of the Group over the period since the beginning of the financial year.

Sir David McMurtry CBE, RDIFREng, CEng, FIMechE

Chairman and Chief Executive

15th October 2009

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

Telephone number 01453 524524

Website www.renishaw.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMABMTMMMBBIL
Date   Source Headline
6th May 20267:00 amRNSTrading Statement
20th Apr 20267:00 amRNSTrading Statement
8th Apr 20267:00 amRNSBoard Changes
11th Feb 20267:00 amRNSHalf-year Financial Report
29th Jan 202612:00 pmRNSNotice of Half-year Results
28th Nov 202511:00 amRNSHolding(s) in Company
28th Nov 202511:00 amRNSHolding(s) in Company
27th Nov 20256:29 pmRNSHolding(s) in Company
27th Nov 20255:00 pmRNSDirector/PDMR Shareholding
26th Nov 20251:32 pmRNSResult of AGM
26th Nov 20258:30 amRNSShareholdings update
29th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSTrading Statement
21st Oct 20253:02 pmRNSVoting Arrangement
21st Oct 20253:00 pmRNSHolding(s) in Company
21st Oct 20253:00 pmRNSHolding(s) in Company
3rd Oct 20257:00 amRNSAnnual Financial Report
24th Sep 20257:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSNew reporting segments for FY2026
18th Sep 20257:00 amRNSFinal Results
21st Aug 20257:00 amRNSBoard Change and Trading Update
13th Aug 20257:00 amRNSDirectorate Change
17th Jun 20257:00 amRNSCapital Markets Day
8th May 20257:00 amRNSTrading Statement
14th Apr 20259:49 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSHalf-year Report
9th Dec 20242:02 pmRNSDeath of Sir David McMurtry
27th Nov 20242:44 pmRNSResult of AGM
29th Oct 20241:28 pmRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSTrading Statement
27th Sep 20247:15 amRNSAnnual Financial Report
12th Sep 20247:00 amRNSFinal Results
29th Aug 20242:00 pmRNSNotice of Results
1st Jul 20247:00 amRNSDirectorate Change
13th Jun 20247:00 amRNSDirectorate Change
16th May 20242:25 pmRNSAGM Voting Results Update Statement
8th May 20247:00 amRNSTrading Statement
2nd Apr 20245:19 pmRNSStatement regarding Renishaw plc
6th Feb 20247:00 amRNSHalf-year Report
30th Jan 202410:30 amRNSChange of Adviser
23rd Jan 20249:00 amRNSNotice of Half-year Results
29th Nov 20232:47 pmRNSResult of AGM
26th Oct 20237:00 amRNSTrading Statement
13th Oct 20237:00 amRNSNotice of AGM
3rd Oct 20237:00 amRNSAnnual Financial Report
19th Sep 20237:00 amRNSFinal Results
13th Sep 20237:00 amRNSRevised date for publication of results
21st Aug 20233:00 pmRNSDirectorate Change
12th Jul 20232:30 pmRNSVoting Arrangement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.